logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
D

Daniela Žáčková

university hospital brno
H指数:15
被引数:612

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study

质子泵抑制剂联合用药与达沙替尼治疗慢性髓性白血病患者的治疗转换之间的关联：一项德国真实世界证据研究

Annals of Hematology
IF2.4
2026-07-300
OA
Sabrina Mueller; Chen-Chia Pan; Jan Bosák; Jiří Hofmann; Florian O. Losch; Thomas Wilke; Barthold Deiters; Daniela Žáčková
The adverse prognostic impact of HMGCLL1 gene variants can be abrogated by frontline second-generation tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

HMGCLL1基因变异的不良预后影响可通过一线二代酪氨酸激酶抑制剂疗法在慢性髓系白血病患者中消除。

Leukemia
IF13.4
2026-03-300
PRE
Maria Agustina Perusini; Katia Pagnano; Carolina Pavlovsky; Daniela Žáčková; Jiří Mayer; Beatriz Moiraghi; Ana Ines Varela; Michele Bianchini; Ana Beatriz Pascoal Lopes; Gislaine Duarte; Carmino Antonio de Souza; Ivana Ježíšková; Anežka Kvetková; Tomáš Jurček; Hye Won Lee; Myung Hee Chang; Jessie J. F. Medeiros; Sagi Abelson; Dennis Dong Hwan Kim
Development of a prognostic scoring system for chronic myeloid leukemia in blast phase

慢性髓性白血病急变期预后评分系统的开发

Leukemia
IF13.4
2026-02-190
OA
Michael Lauseker; Tomasz Sacha; Hana Klamova; Julia Yakoleva; Elza Lomaia; Dragana Milojkovic; Christian Fabisch; Franck E. Nicolini; Ulla Olsson-Stromberg; Daniela Zackova; Krzysztof Lewandowski; Philipp Ernst; Fausto Castagnetti; Klaus Hirschbühl; Irena Zupan; Astghik Voskanyan; Aleksandra Gołos; Jochen J. Frietsch; Justyna Gil; Edgar Faber; Stefan W. Krause; Anne Parry; Susanne Saussele; Sonja Heibl; Georg-Nikolaus Franke; Luis Felipe Casado; Edyta Paczkowska; Holger Hebart; Matthias Eder; Peter Anhut; Karolin Trautmann-Grill; Elzbieta Szczepanek; Thomas Südhoff; Elzbieta Patkowska; Alexander Kiani; Thomas Ernst; Jane Apperley; Jiri Mayer; Andreas Hochhaus; Markus Pfirrmann; Annamaria Brioli
Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia

慢性髓性白血病诊断时额外染色体异常的临床及预后意义

AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2025-01-280
PRE
Mayer, J; Cicatkova, P; Kovácova, L; Jarosová, M; Karas, M; Jindra, P; Klamová, H; Poláková, KM; Cerná, O; Cmunt, E; Belohlávková, P; Zák, P; Faber, E; Papajík, T; Stejskal, L; Jezísková, I; Weinbergerová, B; Jurcek, T; Hornák, T; Zácková, D; Ransdorfová, S; Holzerová, M; Pavlík, T
Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial
LEUKEMIA
IF13.4
2024-07-102
PRE
Efficace, Fabio; Mahon, Francois-Xavier; Richter, Johan; Piciocchi, Alfonso; Cipriani, Marta; Nicolini, Franck E.; Mayer, Jiri; Zackova, Daniela; Janssen, Jeroen J. W. M.; Panayiotidis, Panayiotis; Vestergaard, Hanne; Koskenvesa, Perttu; Almeida, Antonio; Hjorth-Hansen, Henrik; Martinez-Lopez, Joaquin; Olsson-Stromberg, Ulla; Hochhaus, Andreas; Berger, Marc G.; Etienne, Gabriel; Klamova, Hana; Faber, Edgar; Rousselot, Philippe; Pfirrmann, Markus; Saussele, Susanne
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes
BLOOD ADVANCES
IF7.1
2024-05-171
OAAI
Perusini, Maria Agustina; Zackova, Daniela; Kim, Taehyung; Pagnano, Katia; Pavlovsky, Carolina; Jeziskova, Ivana; Kvetkova, Anezka; Jurcek, Tomas; Kim, Jaeyoon; Yoo, Youngseok; Yi, Seongyoon; Lee, Hyewon; Kim, Kyoung Ha; Chang, Myunghee; Capo-Chichi, Jose-Mario; Medeiros, Jessie J. F.; Arruda, Andrea; Minden, Mark; Zhang, Zhaolei; Abelson, Sagi; Mayer, Jiri; Kim, Dennis Dong Hwan
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry
LEUKEMIA
IF13.4
2024-03-284
OAAI
Brioli, Annamaria; Lomaia, Elza; Fabisch, Christian; Sacha, Tomasz; Klamova, Hana; Morozova, Elena; Golos, Aleksandra; Ernst, Philipp; Olsson-Stromberg, Ulla; Zackova, Daniela; Nicolini, Franck E.; Bao, Han; Castagnetti, Fausto; Patkowska, Elzbieta; Mayer, Jiri; Hirschbuehl, Klaus; Podgornik, Helena; Paczkowska, Edyta; Parry, Anne; Ernst, Thomas; Voskanyan, Astghik; Szczepanek, Elzbieta; Saussele, Susanne; Franke, Georg-Nikolaus; Kiani, Alexander; Faber, Edgar; Krause, Stefan; Casado, Luis Felipe; Lewandowski, Krzysztof; Eder, Matthias; Anhut, Peter; Gil, Justyna; Suedhoff, Thomas; Hebart, Holger; Heibl, Sonja; Pfirrmann, Markus; Hochhaus, Andreas; Lauseker, Michael
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
LEUKEMIA
IF13.4
2024-03-120
OAAI
Zackova, Daniela; Semerad, Lukas; Faber, Edgar; Klamova, Hana; Stejskal, Lukas; Belohlavkova, Petra; Karas, Michal; Cmunt, Eduard; Cerna, Olga; Prochazkova, Jirina; Cicatkova, Petra; Kvetkova, Anezka; Hornak, Tomas; Skoumalova, Ivana; Srbova, Dana; Salek, Cyril; Buffa, David; Voglova, Jaroslava; Jurcek, Tomas; Folta, Adam; Jeziskova, Ivana; Zizkova, Hana; Polakova, Katerina Machova; Papajik, Tomas; Zak, Pavel; Jindra, Pavel; Svobodnik, Adam; Stepanova, Radka; Mayer, Jiri
De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-02-051
OAAI
Hornak, Tomas; Mayer, Jiri; Cicatkova, Petra; Semerad, Lukas; Kvetkova, Anezka; Klamova, Hana; Faber, Edgar; Belohlavkova, Petra; Karas, Michal; Stejskal, Lukas; Cmunt, Eduard; Cerna, Olga; Srbova, Dana; Zizkova, Hana; Vrablova, Lucia; Skoumalova, Ivana; Voglova, Jaroslava; Jurkova, Tereza; Chrapava, Marika; Jurcek, Tomas; Jeziskova, Ivana; Jarosova, Marie; Polakova, Katerina Machova; Papajik, Tomas; Zak, Pavel; Jindra, Pavel; Zackova, Daniela
The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib

药物转运体OCTN1基因启动子中的SNP rs460089对伊马替尼治疗的慢性粒细胞白血病患者的无治疗缓解具有预后价值

LEUKEMIA
IF13.4
2023-12-213
OAAI
Polakova, Katerina Machova; Albeer, Ali; Polivkova, Vaclava; Krutska, Monika; Vlcanova, Katerina; Curik, Nikola; Fabarius, Alice; Klamova, Hana; Spiess, Birgit; Waller, Cornelius F.; Bruemmendorf, Tim H.; Dengler, Jolanta; Kunzmann, Volker; Burchert, Andreas; Belohlavkova, Petra; Mustjoki, Satu; Faber, Edgar; Mayer, Jiri; Zackova, Daniela; Panayiotidis, Panayiotis; Richter, Johan; Hjorth-Hansen, Henrik; Kaminska, Magdalena; Plonka, Magdalena; Szczepanek, Elzbieta; Szarejko, Monika; Bober, Grazyna; Hus, Iwona; Grzybowska-Izydorczyk, Olga; Wasilewska, Ewa; Paczkowska, Edyta; Niesiobedzka-Krezel, Joanna; Giannopoulos, Krzysztof; Mahon, Francois X.; Sacha, Tomasz; Saussele, Susanne; Pfirrmann, Markus
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
LEUKEMIA
IF13.4
2022-06-0810
OAAI
Salmon, Matthew; White, Helen E.; Zizkova, Hana; Gottschalk, Andrea; Motlova, Eliska; Cerveira, Nuno; Colomer, Dolors; Coriu, Daniel; Franke, Georg N.; Gottardi, Enrico; Izzo, Barbara; Jurcek, Tomas; Lion, Thomas; Schaefer, Vivien; Venturi, Claudia; Vigneri, Paolo; Zawada, Magdalena; Zuna, Jan; Hovorkova, Lenka; Koblihova, Jitka; Klamova, Hana; Markova, Marketa Stastna; Srbova, Dana; Benesova, Adela; Polivkova, Vaclava; Zackova, Daniela; Mayer, Jiri; Roeder, Ingo; Glauche, Ingmar; Ernst, Thomas; Hochhaus, Andreas; Polakova, Katerina Machova; Cross, Nicholas C. P.
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
LEUKEMIA
IF13.4
2021-02-1515
OAAI
Richter, Johan; Lubking, Anna; Soderlund, Stina; Lotfi, Kourosh; Markevarn, Berit; Sjalander, Anders; Stenke, Leif; Deneberg, Stefan; Ahlstrand, Erik; Myhr-Eriksson, Kristina; Panayiotidis, Panayiotis; Gedde-Dahl, Tobias; Zackova, Daniela; Mayer, Jiri; Olsson-Stromberg, Ulla; Mahon, Francois-Xavier; Saussele, Susanne; Hjorth-Hansen, Henrik; Koskenvesa, Perttu
The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia
LEUKEMIA
IF13.4
2020-06-2945
OAAI
Pfirrmann, Markus; Clark, Richard E.; Prejzner, Witold; Lauseker, Michael; Baccarani, Michele; Saussele, Susanne; Guilhot, Francois; Heibl, Sonja; Hehlmann, Rudiger; Faber, Edgar; Turkina, Anna; Ossenkoppele, Gert; Hoglund, Martin; Zaritskey, Andrey; Griskevicius, Laimonas; Olsson-Stromberg, Ulla; Everaus, Hele; Koskenvesa, Perttu; Labar, Boris; Sacha, Tomasz; Zackova, Daniela; Cervantes, Francisco; Colita, Adriana; Zupan, Irena; Bogdanovic, Andrija; Castagnetti, Fausto; Guilhot, Joelle; Hasford, Joerg; Hochhaus, Andreas; Hoffmann, Verena S.
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission
LEUKEMIA
IF13.4
2020-05-2917
OAAI
Polakova, Katerina Machova; Zizkova, Hana; Zuna, Jan; Motlova, Eliska; Hovorkova, Lenka; Gottschalk, Andrea; Glauche, Ingmar; Koblihova, Jitka; Pecherkova, Pavla; Klamova, Hana; Markova, Marketa Stastna; Srbova, Dana; Benesova, Adela; Polivkova, Vaclava; Jurcek, Tomas; Zackova, Daniela; Mayer, Jiri; Ernst, Thomas; Mahon, Francois X.; Saussele, Susanne; Roeder, Ingo; Cross, Nicholas C. P.; Hochhaus, Andreas

研究方向

暂未获取到该数据
J
Jiřı́ Mayer
H 指数:68论文数:1,443被引数:2.8万
H
Hana Klamová
H 指数:23论文数:195被引数:2,813
E
Edgar Faber
H 指数:23论文数:198被引数:2,308
T
Tomáš Jurček
H 指数:13论文数:93被引数:553
K
Kateřina Machová Poláková
H 指数:26论文数:163被引数:2,966
Z
Zdeněk Ráčil
H 指数:35论文数:447被引数:9,342
S
Susanne Saußele
H 指数:52论文数:346被引数:1.4万
A
Andreas Hochhaus
H 指数:127论文数:1,647被引数:9.0万
P
Petra Bělohlávková
H 指数:8论文数:84被引数:352
J
J Voglová
H 指数:13论文数:108被引数:1,169